Correlation Between Nextage Therapeutics and Azrieli

Can any of the company-specific risk be diversified away by investing in both Nextage Therapeutics and Azrieli at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nextage Therapeutics and Azrieli into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nextage Therapeutics and Azrieli Group, you can compare the effects of market volatilities on Nextage Therapeutics and Azrieli and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nextage Therapeutics with a short position of Azrieli. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nextage Therapeutics and Azrieli.

Diversification Opportunities for Nextage Therapeutics and Azrieli

0.49

Correlation Coefficient

Nextage Therapeutics  Azrieli

Very weak diversification

The 3 months correlation between Nextage and Azrieli is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Nextage Therapeutics and Azrieli Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Azrieli Group and Nextage Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nextage Therapeutics are associated (or correlated) with Azrieli. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Azrieli Group has no effect on the direction of Nextage Therapeutics i.e., Nextage Therapeutics and Azrieli go up and down completely randomly.

Pair Corralation between Nextage Therapeutics and Azrieli

Assuming the 90 days trading horizon Nextage Therapeutics is expected to generate 2.28 times more return on investment than Azrieli. However, Nextage Therapeutics is 2.28 times more volatile than Azrieli Group. It trades about 0.1 of its potential returns per unit of risk. Azrieli Group is currently generating about 0.18 per unit of risk. If you would invest  6,700  in Nextage Therapeutics on September 5, 2024 and sell it today you would earn a total of  1,170  from holding Nextage Therapeutics or generate 17.46% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Nextage Therapeutics  vs.  Azrieli Group

Nextage Therapeutics

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Nextage Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Nextage Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Azrieli Group

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Azrieli Group are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Azrieli sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Nextage Therapeutics and Azrieli

The main advantage of trading using opposite Nextage Therapeutics and Azrieli positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nextage Therapeutics position performs unexpectedly, Azrieli can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Azrieli will offset losses from the drop in Azrieli's long position.

The idea behind Nextage Therapeutics and Azrieli Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.